Company intelligence
Inoviv
Accelerating the Development of New Medicines with Targeted Proteomics
Biotechnology
London, GB
21 employees
Founded 2017
3 public signals
About Inoviv
Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development.
Verified activity
Signals from Inoviv
3 published signals
Presence & Recognition
Inoviv announced that the BD and Science team will be exhibiting at the HUPO2026 conference in Singapore with a poster titled 1144 and a booth space titled 229.
Reported by Inoviv
Presence & Recognition
Inoviv won a place in the Innovation Zone at the ELRIG 2026 Drug Discovery conference
Reported by Inoviv
Presence & Recognition
Inoviv will be attending the ELRIG Irish Forum in Belfast to discuss end-to-end targeted MS proteomics services and new full-length Reference Standards products.
Reported by Inoviv